Catalyst Wire Dossier Catalyst Wire Dossier

Gene Therapy for Chronic Granulomatum Disease

· National Institute of Allergy and Infectious Diseases (NIAID)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gene Therapy for Chronic Granulomatum Disease, covering 2018-07-05 to 2018-07-05. Get the full timeline:

Most recent: Clinical Trial Update: Gene Therapy for Chronic Granulomatous Disease [EARLY_Phase 1]

See pricing